Kala Azar: Four-Year Test Seeks Better Ways to Treat a Persistent Disease … – New York Times
Drug Addiction Treatment: Kala Azar: Four-Year Test Seeks Better Ways to Treat a Persistent Disease … – New York Times
 New York Times |
Kala Azar: Four-Year Test Seeks Better Ways to Treat a Persistent Disease …
New York Times A four-year test of drugs to treat a widespread parasitic disease called kala azar was announced on Monday by the governments of India and Bangladesh, Doctors Without Borders, the Drugs for Neglected Diseases Initiative and … Billion People Suffer from Neglected Tropical Diseases |
Drug Addiction Treatment – Google News
Drug Addiction Treatment: NPS Pharmaceuticals Hormone-Replacement Drug Works in Study – BusinessWeek
|
NPS Pharmaceuticals Hormone-Replacement Drug Works in Study
BusinessWeek NPS will submit the treatment, NPSP558, for regulatory approval next year, the Bedminster, New Jersey-based company said in a statement today. The drug would be the first hormone- replacement therapy approved by the US Food and Drug Administration to … NPS Charts Positive Results on Parathyroid Drug NPS wraps another positive PhIII study as parathyroid drug impresses NPS Pharma: Another Phase III Success |
Drug Addiction Treatment – Google News
Drug Addiction Treatment: ‘Triumph’ seen in drug trial for lung disease; gene-targeted treatment for … – New York Daily News
 New York Daily News |
'Triumph' seen in drug trial for lung disease; gene-targeted treatment for …
New York Daily News "Ivacaftor represents a significant advancement in the treatment of CF," said co-author Michael Konstan, chair of the department of pediatrics at Case Western Reserve University School of Medicine. "This drug targets the basic defect of cystic fibrosis … Cystic fibrosis drug shows promise in trial |
Drug Addiction Treatment – Google News
More Drug Addiction Treatment Information…